StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Global full-time employees at year-end by Year

Global full-time employees at year-end (employees)

Moderna Global full-time employees at year-end: 4,700.00 employees in FY2025, down 19.0% from a year earlier.

Latest, FY2025
4,700.00
Period ended Dec 31, 2025
Change on a year earlier
-19.0%
5,800.00 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“We had approximately 4,700 full-time employees in 18 countries as of December 31, 2025 .”

Source: FY2025 10-K ↗

Reported in Form 10-K Item 1 (Human Capital Management).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal full-time employees at year-end (employees)Year on yearSource
FY2025Dec 31, 20254,700.00-19.0%FY2025 10-K ↗
FY2024Dec 31, 20245,800.00+3.6%FY2024 10-K ↗
FY2023Dec 31, 20235,600.00+43.6%FY2023 10-K ↗
FY2022Dec 31, 20223,900.00+44.4%FY2022 10-K ↗
FY2021Dec 31, 20212,700.00+107.7%FY2021 10-K ↗
FY2020Dec 31, 20201,300.00+56.6%FY2020 10-K ↗
FY2019Dec 31, 2019830.00+9.2%FY2019 10-K ↗
FY2018Dec 31, 2018760.00–FY2018 10-K ↗

Breakdown

What makes up global full-time employees at year-end

Cite this data

StockData. (2026). Moderna Global full-time employees at year-end, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/hc-employees

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.